Xvivo Perfusion
Clinical trials sponsored by Xvivo Perfusion, explained in plain language.
-
New registry aims to boost lung transplants by reconditioning donor lungs
Disease control OngoingThis registry follows 315 people who received a lung transplant after the donor lung was treated with the XVIVO Perfusion System, a device that keeps lungs warm and oxygenated outside the body. Researchers are tracking survival and lung function for up to 5 years to see how well …
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart transplant breakthrough: keeping donor hearts beating during transport could save more lives
Disease control OngoingThis study compares a new method of preserving donor hearts (keeping them warm and beating with blood flow) to the standard cold storage method. The goal is to see if the new approach leads to better heart function and fewer complications in the first month and year after transpl…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New machine keeps donor hearts alive for transplant
Disease control OngoingThis study tests a new method to preserve hearts from donors after circulatory death. The hearts are kept cool and oxygenated using a special machine during transport. The goal is to see if this helps more people get heart transplants and survive. The study involves 20 adults alr…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart preservation method could expand donor pool for transplants
Disease control OngoingThis study looks at a new way to keep donor hearts healthy during transport for transplantation. It involves 141 adults with heart failure who are on the transplant list. The goal is to see if this method is safe and effective for using hearts from extended criteria donors.
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC